China Best Nitroxoline Suppliers for Anticancer Research?

Cancer research depends on promising ideas and dependable materials. IARC’s Global Cancer Observatory estimated 20 million new cancer cases worldwide in 2022, underscoring the need for rigorous research and reproducible laboratory work. Those numbers describe disease burden, not proof that any particular compound will become a treatment.

Nitroxoline As An Anticancer Agent is an emerging research topic, not an established cancer therapy. Published laboratory studies have explored biological mechanisms, including effects on tumor-related pathways, but early findings do not establish clinical benefit. Evidence remains limited. That distinction is easy to overlook when a supplier page uses confident language. Researchers should review primary studies, methods, and limitations before drawing conclusions.

For teams assessing China-based nitroxoline suppliers, product identity and documentation matter as much as price. Request a current certificate of analysis, analytical method details, batch-specific purity results, and storage and shipping information. Check whether the seller can provide traceable quality records and respond clearly to technical questions. A catalog listing alone is not verification. IARC data can establish the scale of cancer research needs; it cannot validate a reagent or supplier. Procurement decisions should therefore rely on independently reviewable specifications and institutional quality procedures. Even then, paperwork has limits: the actual batch must match its documented composition. This guide examines supplier selection through that practical lens, while keeping scientific claims proportionate to the available evidence.

Table of Contents [Hide]

1 Nitroxoline: Chemical Identity and Research Background

2 Anticancer Research Applications and Current Evidence

3 China-Based Supplier Selection Criteria

4 Product Quality, Documentation, and Regulatory Compliance

5 Safe Handling and Responsible Research Use

Nitroxoline: Chemical Identity and Research Background

Nitroxoline is a small molecule with the formula C9H6N2O and a molecular weight of 162.15 g/mol, according to PubChem. Its quinoline structure and nitrogen and oxygen atoms help define its chemical identity. A small molecule. For research use, these identifiers are practical checks, not substitutes for testing. Confirm the lot’s identity and purity using suitable analytical methods, and review its certificate of analysis.

Nitroxoline is known as an antimicrobial compound, while laboratory studies have also examined its potential anticancer activity. These research directions should not be confused with established cancer treatment. The IARC Global Cancer Observatory estimated 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022. That burden helps explain scientific interest in new research candidates, but it does not validate any particular compound. Results can vary with cell models, concentrations, and study design. Still, not proof. Researchers should record the material’s batch, storage conditions, and assay details so findings can be interpreted and reproduced. Sources: PubChem Compound Summary; IARC Global Cancer Observatory, 2022 estimates.

Anticancer Research Applications and Current Evidence

Anticancer Research Applications and Current Evidence
Nitroxoline is an antimicrobial medicine being explored in laboratory cancer research. Researchers have investigated its effects on cancer-cell growth and possible influences on metal-dependent enzymes and cellular signaling. Findings remain early. Results from cell cultures or animal models cannot establish safety or effectiveness in people. Evidence differs across cancer types, experimental conditions, and study methods. That distinction matters.

Tips: Check the compound’s identity, purity documentation, and batch consistency before comparing results. Record solvent, concentration, exposure time, and controls. Small details can shift an assay.

For reliable interpretation, compare findings across independent studies and note each model’s limitations. A visible change in a dish is not a clinical outcome. Some experiments may use concentrations that are difficult to translate into human treatment. This is a real gap, and it deserves scrutiny. Researchers should report negative results and avoid presenting proposed mechanisms as proven explanations. Nitroxoline’s anticancer potential remains a research question, not an established treatment claim.

China-Based Supplier Selection Criteria

China Best Nitroxoline Suppliers for Anticancer Research?

China-Based Supplier Selection Criteria

For anticancer research, assess China-based nitroxoline suppliers as analytical partners, not just price sources. Request a lot-specific certificate of analysis, chromatograms, assay methods, and impurity data. Check that the vial, certificate, and shipping documents show matching batch numbers. Small mismatch? Pause.

The World Health Organization’s 2017 study estimated that one in ten medical products in low- and middle-income countries is substandard or falsified. This is not a nitroxoline-specific estimate, but it highlights the value of traceable documentation.

A 2021 OECD and EUIPO report estimated counterfeit goods represented 2.5% of world trade in 2019. These broad figures cannot predict reagent quality; they do support verification beyond paperwork.

Ask for recent independent test results, including methods and detection limits. Compare multiple lots for assay and impurity consistency before planning cell-based experiments. Check the manufacturing site, change-control practices, storage conditions, and export documents. A neat PDF is not proof. Supplier specifications are a starting point, not a verdict. Confirm chemical identity and purity separately from any unvalidated claim about anticancer effects.

Product Quality, Documentation, and Regulatory Compliance

Choosing a China-based nitroxoline supplier for anticancer research requires more than a competitive quotation. Request a lot-specific certificate of analysis, chromatographic purity data, identity testing, and clear storage conditions. Check that the batch number on the vial matches its documents. Ask about retest dates, shipping temperature controls, and change-notification practices. Small details matter.

WHO’s 2017 estimate that one in ten medical products in low- and middle-income countries is substandard or falsified is a broad supply-chain warning, not a finding about research-grade nitroxoline. Still, it supports careful verification. Compare supplier quality procedures with relevant ICH Q7 principles, and request traceable test methods and records. A polished certificate alone is not enough.

Review the safety data sheet, country-of-origin details, and export and import documentation before ordering. Confirm that the stated material is intended for laboratory research, not human use, and check applicable local requirements. For a received batch, inspect the sealed container, label, and packaging condition, then retain a sample for independent testing if the project warrants it. Paperwork can look tidy while a vial tells another story. I would still want clearer stability data when the supplier provides only a retest date. (Source: WHO, “Substandard and falsified medical products,” 2017.)

China Best Nitroxoline Suppliers for Anticancer Research? – Product Quality, Documentation, and Regulatory Compliance

Evaluation Area	Relevant Data	What to Verify with a Supplier	Why It Matters for Anticancer Research
Compound identity	Nitroxoline; also described as 5-nitro-8-hydroxyquinoline.	Confirm the product name and chemical identity match across the label, certificate of analysis (CoA), and safety data sheet (SDS).	Correct identification helps prevent mix-ups with structurally related compounds.
CAS Registry Number	4008-48-4.	Check that the CAS number is consistent across product documents and the shipment label.	Provides a standard identifier for ordering, documentation, and literature checks.
Molecular formula and molecular weight	C₉H₆N₂O₃; approximately 190.16 g/mol.	Compare the stated formula and molecular weight with the product specification and analytical records.	Supports preparation of solutions and confirmation of experimental calculations.
Established pharmacological context	Nitroxoline is an antibacterial agent used in some countries for urinary tract infections; approved uses vary by jurisdiction.	Request a clear statement of the product’s intended use and confirm applicable local requirements.	Its established antibacterial use should not be confused with an approved anticancer indication.
Anticancer research status	Nitroxoline has been investigated in preclinical anticancer research. Preclinical findings do not establish clinical benefit or approval as a cancer treatment.	Check primary research papers and distinguish laboratory or animal findings from clinical evidence.	Helps keep study rationale, communications, and conclusions evidence-based.
Purity and assay	Purity specifications are product- and batch-specific; there is no single universal research-grade threshold.	Request a batch-specific CoA stating the assay or purity result, test method, acceptance criteria, and reporting basis.	Purity can affect reproducibility, dose calculations, and interpretation of biological results.
Identity and analytical testing	Identity and purity may be supported by suitable analytical methods, such as chromatography and spectroscopic techniques.	Ask which methods were used and whether chromatograms or other supporting data are available for the supplied batch.	Analytical evidence helps assess whether the material is consistent with its stated identity and specification.
Impurity information	Impurity profiles and limits should be defined in the product specification where applicable.	Review specified impurities, residual solvents or other relevant limits, and the method used to assess them.	Uncharacterized impurities may introduce confounding effects in cell-based or other assays.
Batch traceability	A lot or batch number should link the product container to its quality records.	Confirm batch number, manufacturing or retest information where provided, and traceability on the CoA and packaging.	Traceability supports investigation of unexpected results and repeat experiments.
Documentation package	Commonly relevant documents include a batch-specific CoA, SDS, product specification, and handling information.	Check that documents are current, internally consistent, and tied to the product or batch being purchased.	Complete records support laboratory safety, quality review, and research reproducibility.
Regulatory and intended-use statements	Research-use materials are not automatically suitable or authorized for administration to humans or animals.	Review intended-use wording, import and local compliance requirements, and any claims concerning GMP or other quality systems.	Prevents research materials from being mistaken for clinical or therapeutic products.
Packaging and handling	Handling and storage conditions should follow the supplier’s product-specific instructions and SDS.	Check container integrity, labeling, recommended storage, and any shipment or handling precautions.	Appropriate handling helps preserve sample integrity and protects laboratory personnel.

Important: This table is a supplier-evaluation guide, not a ranking or endorsement of any supplier. Nitroxoline is not established here as an approved anticancer treatment; verify current scientific evidence and applicable regulatory requirements before use.

Safe Handling and Responsible Research Use

Nitroxoline’s established pharmaceutical history does not establish safety for laboratory research. Before accepting a batch, request its current safety data sheet, certificate of analysis, and storage and transport details. Check the material’s identity, purity, and stated limitations against your approved research protocol. A certificate cannot replace a hazard assessment. If documentation is incomplete, pause and ask the supplier for clarification.

Handle the material under your institution’s chemical hygiene plan, using a suitable ventilated enclosure when the assessment requires one. Wear a closed lab coat, eye protection, and gloves selected from the SDS guidance. Keep containers sealed, labeled, and away from food areas. OSHA’s Laboratory Standard, 29 CFR 1910.1450, requires a written Chemical Hygiene Plan and its annual review. NIOSH’s hierarchy of controls places engineering controls above reliance on personal protective equipment alone. That distinction matters at the bench. A glove is not a ventilation system. I would not infer that a compound is harmless because it is familiar or intended for research. Record handling, spills, and disposal according to local procedures, and report uncertainty early. It is easy to miss a small detail. Do not improvise.